annual CFI:
-$2.53B+$848.51M(+25.13%)Summary
- As of today (September 17, 2025), TAK annual cash flow from investing activities is -$2.53 billion, with the most recent change of +$848.51 million (+25.13%) on March 1, 2025.
- During the last 3 years, TAK annual CFI has fallen by -$708.39 million (-38.94%).
- TAK annual CFI is now -168.38% below its all-time high of $3.70 billion, reached on March 31, 2021.
Performance
TAK Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$265.02M-$126.17M(-90.86%)Summary
- As of today (September 17, 2025), TAK quarterly cash flow from investing activities is -$265.02 million, with the most recent change of -$126.17 million (-90.86%) on June 1, 2025.
- Over the past year, TAK quarterly CFI has increased by +$769.65 million (+74.39%).
- TAK quarterly CFI is now -107.83% below its all-time high of $3.39 billion, reached on September 30, 2019.
Performance
TAK quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$1.75B+$769.65M(+30.53%)Summary
- As of today (September 17, 2025), TAK TTM cash flow from investing activities is -$1.75 billion, with the most recent change of +$769.65 million (+30.53%) on June 1, 2025.
- Over the past year, TAK TTM CFI has increased by +$699.07 million (+28.53%).
- TAK TTM CFI is now -146.94% below its all-time high of $3.73 billion, reached on March 31, 2021.
Performance
TAK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TAK Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.1% | +74.4% | +28.5% |
| 3 y3 years | -38.9% | +63.9% | +8.4% |
| 5 y5 years | -198.4% | -10000.0% | -159.2% |
TAK Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.9% | +44.4% | -90.9% | +92.0% | -17.6% | +71.4% |
| 5 y | 5-year | -168.4% | +44.4% | -109.5% | +92.0% | -146.9% | +71.4% |
| alltime | all time | -168.4% | +90.2% | -107.8% | +98.2% | -146.9% | +93.2% |
TAK Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$265.02M(+90.9%) | -$1.75B(-30.5%) |
| Mar 2025 | -$2.53B(-25.1%) | -$138.85M(-83.3%) | -$2.52B(-13.8%) |
| Dec 2024 | - | -$829.34M(+60.1%) | -$2.92B(+13.3%) |
| Sep 2024 | - | -$517.96M(-49.9%) | -$2.58B(+5.4%) |
| Jun 2024 | - | -$1.03B(+90.7%) | -$2.45B(-27.3%) |
| Mar 2024 | -$3.38B(-25.7%) | -$542.58M(+11.6%) | -$3.37B(-45.0%) |
| Dec 2023 | - | -$486.27M(+25.7%) | -$6.13B(+2.6%) |
| Sep 2023 | - | -$386.73M(-80.2%) | -$5.97B(+3.2%) |
| Jun 2023 | - | -$1.96B(-40.7%) | -$5.79B(+26.8%) |
| Mar 2023 | -$4.54B(+149.7%) | -$3.30B(+904.9%) | -$4.56B(+206.4%) |
| Dec 2022 | - | -$328.35M(+62.8%) | -$1.49B(-17.3%) |
| Sep 2022 | - | -$201.71M(-72.5%) | -$1.80B(-5.8%) |
| Jun 2022 | - | -$734.16M(+226.0%) | -$1.91B(+4.7%) |
| Mar 2022 | -$1.82B(-149.2%) | -$225.20M(-64.8%) | -$1.83B(-252.8%) |
| Dec 2021 | - | -$638.98M(+104.1%) | $1.20B(-52.4%) |
| Sep 2021 | - | -$313.14M(-51.7%) | $2.51B(-18.5%) |
| Jun 2021 | - | -$648.39M(-123.2%) | $3.08B(-17.4%) |
| Mar 2021 | $3.70B(+43.9%) | $2.80B(+312.4%) | $3.73B(+203.7%) |
| Dec 2020 | - | $678.00M(+165.6%) | $1.23B(-818.9%) |
| Sep 2020 | - | $255.24M(>+9900.0%) | -$170.89M(-105.8%) |
| Jun 2020 | - | $1.65M(-99.4%) | $2.96B(+15.9%) |
| Mar 2020 | $2.57B(-110.0%) | $293.60M(-140.7%) | $2.55B(-128.6%) |
| Dec 2019 | - | -$721.38M(-121.3%) | -$8.94B(-60.5%) |
| Sep 2019 | - | $3.39B(-939.1%) | -$22.63B(-12.6%) |
| Jun 2019 | - | -$403.43M(-96.4%) | -$25.89B(+0.9%) |
| Mar 2019 | -$25.65B(+2648.2%) | -$11.20B(-22.2%) | -$25.66B(+66.3%) |
| Dec 2018 | - | -$14.41B(<-9900.0%) | -$15.42B(+1283.7%) |
| Sep 2018 | - | $130.46M(-175.2%) | -$1.11B(-42.5%) |
| Jun 2018 | - | -$173.58M(-82.2%) | -$1.94B(+109.0%) |
| Mar 2018 | -$933.42M(-84.7%) | -$973.37M(+891.2%) | -$927.56M(-83.3%) |
| Dec 2017 | - | -$98.20M(-85.8%) | -$5.57B(-3.4%) |
| Sep 2017 | - | -$693.37M(-182.8%) | -$5.76B(+12.3%) |
| Jun 2017 | - | $837.38M(-114.9%) | -$5.13B(-15.0%) |
| Mar 2017 | -$6.11B(+850.5%) | -$5.61B(+1794.3%) | -$6.04B(+2679.2%) |
| Dec 2016 | - | -$296.23M(+387.1%) | -$217.29M(-48.2%) |
| Sep 2016 | - | -$60.82M(-13.5%) | -$419.20M(-20.8%) |
| Jun 2016 | - | -$70.33M(-133.5%) | -$529.27M(-17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | -$642.54M(-195.2%) | $210.10M(-142.2%) | -$643.70M(-36.6%) |
| Dec 2015 | - | -$498.14M(+191.5%) | -$1.01B(-626.5%) |
| Sep 2015 | - | -$170.89M(-7.5%) | $192.73M(-39.5%) |
| Jun 2015 | - | -$184.76M(+14.8%) | $318.61M(-58.7%) |
| Mar 2015 | $674.71M(-142.6%) | -$160.98M(-122.7%) | $771.02M(-17.3%) |
| Dec 2014 | - | $709.36M(-1676.1%) | $931.99M(+318.6%) |
| Sep 2014 | - | -$45.01M(-116.8%) | $222.64M(-16.8%) |
| Jun 2014 | - | $267.64M(-439.2%) | $267.64M(-122.9%) |
| Mar 2014 | -$1.58B(+0.2%) | - | - |
| Mar 2013 | -$1.58B(-88.6%) | - | - |
| Mar 2012 | -$13.85B(+1095.4%) | - | - |
| Mar 2011 | -$1.16B(-8.4%) | -$78.89M(-79.1%) | -$1.17B(-32.0%) |
| Dec 2010 | - | -$377.85M(-21.3%) | -$1.72B(+9.0%) |
| Sep 2010 | - | -$480.29M(+106.5%) | -$1.58B(+23.7%) |
| Jun 2010 | - | -$232.56M(-63.1%) | -$1.28B(+0.2%) |
| Mar 2010 | -$1.27B(-83.4%) | -$630.38M(+166.9%) | -$1.27B(+97.8%) |
| Dec 2009 | - | -$236.19M(+33.0%) | -$644.27M(+57.9%) |
| Sep 2009 | - | -$177.54M(-23.0%) | -$408.08M(+77.0%) |
| Jun 2009 | - | -$230.54M | -$230.54M |
| Mar 2009 | -$7.63B(-956.9%) | - | - |
| Mar 2008 | $890.28M(-10.6%) | - | - |
| Mar 2007 | $995.56M(+1616.2%) | - | - |
| Mar 2006 | $58.01M(-108.6%) | - | - |
| Mar 2005 | -$672.67M(-45.4%) | - | - |
| Mar 2004 | -$1.23B(-207.2%) | - | - |
| Mar 2003 | $1.15B(+14.7%) | - | - |
| Mar 2002 | $1.00B(-290.3%) | - | - |
| Mar 2001 | -$526.74M(+13.5%) | - | - |
| Mar 2000 | -$464.03M(-65.2%) | - | - |
| Mar 1999 | -$1.33B(+124.9%) | - | - |
| Mar 1998 | -$592.35M(+48.4%) | - | - |
| Mar 1997 | -$399.05M(-14.0%) | - | - |
| Mar 1996 | -$463.90M(-21.3%) | - | - |
| Mar 1995 | -$589.34M(+56.5%) | - | - |
| Mar 1994 | -$376.52M(+66.5%) | - | - |
| Mar 1993 | -$226.11M(-1.9%) | - | - |
| Mar 1992 | -$230.46M(-10.4%) | - | - |
| Mar 1991 | -$257.11M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CFI year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CFI year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM cash flow from investing activities?
- What is the all time high TTM CFI for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CFI year-on-year change?
What is Takeda Pharmaceutical Company Limited annual cash flow from investing activities?
The current annual CFI of TAK is -$2.53B
What is the all time high annual CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual cash flow from investing activities is $3.70B
What is Takeda Pharmaceutical Company Limited annual CFI year-on-year change?
Over the past year, TAK annual cash flow from investing activities has changed by +$848.51M (+25.13%)
What is Takeda Pharmaceutical Company Limited quarterly cash flow from investing activities?
The current quarterly CFI of TAK is -$265.02M
What is the all time high quarterly CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly cash flow from investing activities is $3.39B
What is Takeda Pharmaceutical Company Limited quarterly CFI year-on-year change?
Over the past year, TAK quarterly cash flow from investing activities has changed by +$769.65M (+74.39%)
What is Takeda Pharmaceutical Company Limited TTM cash flow from investing activities?
The current TTM CFI of TAK is -$1.75B
What is the all time high TTM CFI for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM cash flow from investing activities is $3.73B
What is Takeda Pharmaceutical Company Limited TTM CFI year-on-year change?
Over the past year, TAK TTM cash flow from investing activities has changed by +$699.07M (+28.53%)